I just can't understand how RHY can sell COLOSTAT in the near to...

I just can't understand how RHY can sell COLOSTAT in the near to medium term

Not published in medial journals that I am aware of
Not recognised/mentioned by any scientists outside of RHY
Not presenting at Australian conferences to showcase COLOSTAT
Not presenting at World conferences to showcase COLOSTAT
No disclosure of sensitivity and specificity for all stages of cancer
No disclosure of sensitivity and specificity for advanced adenomas


Just because RHY has found 2 manufacturing (micro caps) to make the COLOSTAT test kit doesn't mean it will produce them. A lot of water needs to go under the bridge.

FirstSight is not quite ready for commercialisation but far more advanced than RHY with everything they do. They were going down the path of CLIA but due to above average results they are now pursuing the FDA route. This will 100% ensure medicare/medicaid reimburesment.

It will sell for under $200.

Before you say that blood-based testing requires basically NO capital investment, any capital investment and training for a superior product will have a very quick pay off.

Whether these CRC blood testing companies around the world start selling in Australia is anyone's guess.

https://www.medindia.net/health-press-release/cellmax-life-announces-positive-results-from-prospective-multisite-study-of-novel-blood-test-to-detect-colorectal-cancer-and-pre--615923-1.htm

https://www.prweb.com/releases/2023/1/prweb19120238.htm

https://cellmaxlife.com/